GEMINI
A Randomized, Double-Blind, Double-Dummy, Active-controlled, Parallel-group, Multicenter Study to Compare the Safety of Rivaroxaban versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Subjects with ACS
- Stadium
- klaar
- Middel
- rivaroxaban
- Populatie
- ASCVD
- Fase
- II
- First Patient In
- 15 mei 2015
- Last Patient In
- 23 februari 2016
- Last Patient Last Visit
- 23 augustus 2016